In February 2924 it was announced that NightHawk Biosciences / Scorpius Holdings, Inc. (NYSE American: NHWK; SCPX), -- an integrated contract development and manufacturing organization (CDMO), t-- had completed name change of the firm from NightHawk Biosciences, Inc. to Scorpius Holdings, Inc., to better reflect the Companys successful shift into a pure-play, large molecule biomanufacturing CDMO. In connection with the name change, the Companys ticker will change to SCPX effective today, February 6, 2024. The name and symbol changes do not affect the Company's share structure or the rights of the Company's shareholders, and no further action will be required by existing shareholders. Scorpius Holdings Inc. is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic and cell therapy programs to the clinic and beyond. Scorpius offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, TX. With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing.
